Literature DB >> 10505113

Photodynamic treatment of adenoviral vectors with visible light: an easy and convenient method for viral inactivation.

F H Schagen1, A C Moor, S C Cheong, S J Cramer, H van Ormondt, A J van der Eb, T M Dubbelman, R C Hoeben.   

Abstract

Recombinant adenovirus vectors are popular tools for gene transfer and gene therapy. However biosafety constraints require that all handling of the vectors and vector-containing samples is restricted to dedicated containment laboratories, unless they had undergone a validated virus-inactivation procedure, which decontaminates the samples from any active virus. In this study we evaluated the feasibility of photodynamic treatment (PDT) with visible light to inactivate recombinant adenovirus vectors in biological samples, with minimum associated effects on other biological activities. Several photosensitizers were tested for their capacity to inactivate a model human adenovirus vector, AdCMVLuc, upon illumination. Four photosensitizers (methylene blue (MB), rose bengal (RB), uroporphyrin (UP) and aluminum phthalocynine tetrasulphonate (AIPcS4)) could inactivate the adenovirus, as measured by expression of the luciferase reporter gene and by plaque assay. Of these, MB demonstrated to be the most effective sensitizer in phosphate-buffered saline (PBS), giving > 7 log10 inactivation of the adenovirus. DNA isolated from MB- and light-treated virions was inefficient as a template for transcription. Furthermore, Southern blot analysis revealed fragmentation of the viral DNA. Based on its preference for DNA, MB is suited for adenovirus inactivation in blood plasma. Spiking experiments in which AdCMVLuc was added to plasma samples demonstrated a reduction (> 4 log10-fold) of reporter gene expression to almost background levels. In contrast to MB, photodynamic treatment with RB, UP or AIPcS4 did not lead to DNA damage. Although alterations of the viral capsid could not be detected, the binding pattern of the particles to target cells was significantly changed. Taken together, our data demonstrate that PDT is an efficient, convenient and useful method for the inactivation of adenovirus vectors in biological samples.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10505113     DOI: 10.1038/sj.gt.3300897

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  11 in total

1.  Early host cell reactivation of an oxidatively damaged adenovirus-encoded reporter gene requires the Cockayne syndrome proteins CSA and CSB.

Authors:  Derrik M Leach; Andrew J Rainbow
Journal:  Mutagenesis       Date:  2010-11-08       Impact factor: 3.000

2.  Frequency, proliferation, and activation of human memory T cells induced by a nonhuman adenovirus.

Authors:  Matthieu Perreau; Eric J Kremer
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset.

Authors:  D Rea; F H Schagen; R C Hoeben; M Mehtali; M J Havenga; R E Toes; C J Melief; R Offringa
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

4.  T-cell response to viral antigens in adults and children with common variable immunodeficiency and specific antibody deficiency.

Authors:  L M Haveman; J Scherrenburg; L J Maarschalk-Ellerbroek; P D Hoek; R Schuurman; W de Jager; P M Ellerbroek; B J Prakken; D van Baarle; J M van Montfrans
Journal:  Clin Exp Immunol       Date:  2010-04-09       Impact factor: 4.330

5.  Defective repair of oxidative dna damage in triple-negative breast cancer confers sensitivity to inhibition of poly(ADP-ribose) polymerase.

Authors:  Elizabeth Alli; Vandana B Sharma; Preethi Sunderesakumar; James M Ford
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

6.  Extensive cross-reactivity of CD4+ adenovirus-specific T cells: implications for immunotherapy and gene therapy.

Authors:  Bianca Heemskerk; Louise A Veltrop-Duits; Tamara van Vreeswijk; Monique M ten Dam; Sebastiaan Heidt; Rene E M Toes; Maarten J D van Tol; Marco W Schilham
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

Review 7.  Chemical and biological mechanisms of pathogen reduction technologies.

Authors:  Janna M Mundt; Lindsay Rouse; Jeroen Van den Bossche; Raymond P Goodrich
Journal:  Photochem Photobiol       Date:  2014-08-20       Impact factor: 3.421

Review 8.  Photodynamic inactivation of mammalian viruses and bacteriophages.

Authors:  Liliana Costa; Maria Amparo F Faustino; Maria Graça P M S Neves; Angela Cunha; Adelaide Almeida
Journal:  Viruses       Date:  2012-06-26       Impact factor: 5.048

Review 9.  Can biowarfare agents be defeated with light?

Authors:  Fatma Vatansever; Cleber Ferraresi; Marcelo Victor Pires de Sousa; Rui Yin; Ardeshir Rineh; Sulbha K Sharma; Michael R Hamblin
Journal:  Virulence       Date:  2013-09-25       Impact factor: 5.882

10.  Inactivation of Streptomyces phage ɸC31 by 405 nm light: Requirement for exogenous photosensitizers?

Authors:  Rachael M Tomb; Michelle Maclean; Paul R Herron; Paul A Hoskisson; Scott J MacGregor; John G Anderson
Journal:  Bacteriophage       Date:  2014-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.